​QQQ Chart Set-Up Crying Wolf … Again!

Mike Paulenoff  |

The chart set-up that cried Wolf — my weekly chart of the QQQ's — is at it again, threatening to stalk overzealous holders of technology long positions. I really don't know if the wolf is a real threat this time or not, but the attached chart set-up certainly is warning us not to be surprised if it is the real thing.

QQQ hit its confirmed (by momentum) price high on Jan 26 of this year at 170.95, but after that, every subsequent high has been accompanied by a lower high in momentum. This week's all-time new high at 182.93 (on Wed Jul 27) represented the third unconfirmed new all-time high since January.

In my experience, the greater the number of consecutive upside momentum divergences, the more vicious the ensuing correction. This occurs in any and every market set up, which is especially true on a BIG picture WEEKLY timeframe (as is the shown on the attached QQQ weekly chart).

In addition, let's notice that this week's candle exhibits a potentially very bearish new all-time-high, long-tail downside reversal accompanied by the third glaring weekly momentum divergence since January.

The technical conditions are in place for a wicked bout of weakness in the QQQ. Two of the 5 charter members of FAANG have been badly wounded (FB, NFLX, not to mention drubbing of non-FAANG's INTC and TWTR). In addition to wondering about AMZN's 4% downside ricochet off of its post-EPS, unconfirmed new all-time high at 1896.40, at its 9-month upper channel boundary line (see link to AMZN chart below), I think we could have more to worry about than most people suspect heading into AAPL's earnings next Tuesday after the close.

See charts illustrating the technical pattern of the QQQQ and AMZN.

Mike Paulenoff is a veteran technical strategist and financial author, and host of MPTrader.com, a live trading room of his market analysis and stock trading alerts. Sign Up for a Free 15-Day Trial to Mike's Live Trading Room!

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Symbol Name Price Change % Volume
FB Facebook Inc. 173.80 -0.90 -0.52 24,893,176 Trade
INTC Intel Corporation 47.10 -0.07 -0.15 26,381,992 Trade
AAPL Apple Inc. 217.58 4.26 2.00 35,426,997 Trade
TWTR Twitter Inc. 32.73 -0.10 -0.30 14,874,597 Trade
AMZN Amazon.com Inc. 1,882.22 -4.30 -0.23 4,104,300 Trade
NFLX Netflix Inc. 316.78 -5.66 -1.76 10,407,908 Trade


Emerging Growth

IMV Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.